Publication | Closed Access

Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model

Drug TargetingOncologyPolymer-drug ConjugateMedicineGynecologyTherapeutic EfficacyDrug Delivery SystemsTumor TargetingCancer TreatmentPharmacologyGynecology OncologyOvarian Cancer